24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Carcinoma Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Diagnostic, Neck Cancer, more »


 
1-10 of 68 reports for Carcinoma

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Different types of multidrug resistant cancer cell lines including breast cancer, uterine carcinoma, pancreatic cancer and small-cell lung cancer. Sunshine biopharma also offers difluoro-etoposide, which ...

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Phase ii/b clinical trials for the treatment of pancreatic cancer and for superficial bladder carcinoma cancer, as well as a phase i/iia clinical trial for the treatment of ovarian cancer. Tikcro ...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of adrenocortical carcinoma (adrenal cortex cancer)- the report reviews key pipeline products under drug profile section which includes, product description ...

Squamous Cell Carcinoma - Pipeline Review, H2 2014

Squamous Cell Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

... Of development ranging from pre-registration till discovery and undisclosed stages- a detailed assessment of monotherapy and combination therapy pipeline projects- coverage of the squamous cell carcinoma ...

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

... Epidemiological forecast for the diagnosed prevalent cases of cs, cushing's disease, ectopic- adrenocorticotropic hormone (acth) cs, adrenal adenoma cs, and adrenal carcinoma cs segmented by age (18 to =85 years ...

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2014, Global Markets Direct

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

... Therapeutic landscape of metastatic hepatocellular carcinoma (hcc)- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Renal Cell Carcinoma - Pipeline Review, H2 2014

Renal Cell Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of renal cell carcinoma- the report reviews key pipeline products under drug profile section which includes, product description, mo ...

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

... Therapeutic landscape of head and neck cancer squamous cell carcinoma- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of recurrent head and neck cancer squamous cell carcinoma- the report reviews key pipeline products under drug profile section which ...

Global Non-small Cell Lung Cancer Market 2014-2018

Global Non-small Cell Lung Cancer Market 2014-2018

  • $ 2 500
  • Industry report
  • September 2014
  • by Infiniti Research Limited

... Undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without ...

About 1 400 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Italy

  • Digestive and Liver Disease
  • February 2013
    61 pages
  • Pathology  

    Digestive Syste  

  • Italy  

View report >

11 Companies for Carcinoma

Read our Company Profiles

Novartis Inc.

Switzerland

Amgen Inc.

United States

Eli Lilly and Co.

United States

Lilly and Co.

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.